TrialOpen forum infectious diseases2026

A Single Dose Study of Pembrolizumab in People With HIV Infection Who are Immunologic Nonresponders.

Janaki Kuruppu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.